Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).

Radiol Med · 2024 · PMC11021246 · PMID 38369638

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Recently at the ASCO GU 2023 symposium, the 10-year results of the CHHiP trial were presented confirming the non-inferiority of the hypofractionation arm (60 Gy/20 fractions) (HR = 0.84, 95%CI 0.72, 0.97) and a borderline significance for superiority (HR = 0.84, 95%CI 0.70, 1.00).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.